Active inflammatory bowel disease: Evaluation with 99mTc (V) DMSA scintigraphy

Radiology

Volumn 229, Issue 1, 2003, Pages 70-74

  Koutroubakis, Ioannis E ^a   Koukouraki, Sophia I ^a   Dimoulios, Philippos D ^a   Velidaki, Antigoni A ^a   Karkavitsas, Nikolaos S ^a   Kouroumalis, Elias A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Colitis; Crohn disease; Enteritis; Inflammation; Intestines; Radionuclide studies; Ulcerative

Indexed keywords

SUCCIMER TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENTERITIS; EVALUATION; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; ISCHEMIC COLITIS; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 0141853114     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2291020692     Document Type: Article

References (31)

1. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. lndium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986; 90:1121-1128.
2. Giaffer MH, Tindale WB, Holdsworth D. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996; 8:1195-1200.
3. Mairal L, de Lima PA, Martin-Comin J, et al. Simultaneous administration of 111In-human immunoglobulin and 99mTc-HMPAO labelled leucocytes in inflammatory bowel disease. Eur J Nucl Med 1995; 22:664-670.
4. Heresbach D, Bretagne JF, Raoul JL, et al. Indium scanning in assessment of acute Crohn's disease: a prospective study of sensitivity and correlation with severity of mucosal damage. Dig Dis Sci 1993; 38:1601-1607.
5. Gibson P, Lichtenstein M, Salehi N, Hebbard G, Andrews J. Value of positive technetium99m leucocyte scans in predicting intestinal inflammation. Gut 1991; 32:1502-1507.
6. Bhatti M, Chapman P, Peters M, Haskard D, Hodgson HJ. Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut 1998; 43:40-47.
7. Scholmerich J, Schmidt E, Schumichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology 1988; 95:1287-1293.
8. Jaakkola K, Knuuti J, Soderlund K, Saraste A, Jalkanen S, Voipio-Pulkki LM. Labelling lymphocytes with technetium99m-hexamethyl propyleneamine oxime for scintigraphy: an improved labelling procedure. J Immunol Methods 1998; 214:187-197.
9. Mojiminiyi OA, Udelsman R, Soper ND, Shepstone BJ, Dudley NE. Pentavalent Tc-99m DMSA scintigraphy: prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med 1991; 16:259-262.
10. Ohta H, Endo K, Fujita T, et al. Imaging of soft tissue tumors with Tc(V)-99m dimercaptosuccinic acid: a new tumor-seeking agent. Clin Nucl Med 1984; 9:568-573.
11. Kobayashi H, Sakahara H, Hosono M, et al. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy. Radiology 1994; 190:277-280.
12. Banci M, Bianchi PL, Gianni W, et al. Preliminary evaluation of the usefulness of Tc-99m (V) DMSA in pancreatic neuroendocrine tumors. Clin Nucl Med 1996; 21:122-124.
13. Kobayashi H, Kotoura Y, Hosono M, et al. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Clin Nucl Med 1995; 20:361-364.
14. Lee BF, Chen CJ, Yang CC, Yu HS. Psoas muscle abscess causing fever of unknown origin: the value of Tc-99m (V) DMS imaging. Clin Nucl Med 1997; 22:789-790.
15. Lee BF, Chiu NT, Chang JK, Liu GC, Yu HS. Technetium-99m(V)-DMSA and gallium-67 in the assessment of bone and joint infection. J Nucl Med 1998; 39:2128-2131.
16. Lee BF, Chiu NT, Wu DC, et al. Use of 99mTc (V) DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings and colonoscopy and biopsy. Radiology 2001; 220:381-385.
17. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444.
18. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43:29-32.
19. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 24:2-6.
20. Kolkman JJ, Falke TH, Roos JC, et al. Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease: comparison with endoscopy and operative findings. Dig Dis Sci 1996; 41:641-650.
21. Yokoyama A, Hata N, Saji H, et al. Chemically designed Tc99m radiopharmaceuticals for the tumor diagnosis: Tc-99m-DMSA. J Nucl Med 1981; 22:69-71.
22. Ercan MT, Gulaldi NC, Unsal IS, Aydin M, Peksoy I, Hascelik Z. Evaluation of Tc99m(V) DMSA for imaging infiammatory lesions: an experimental study. Ann Nucl Med 1996; 10:419-423.
23. Everitt BS, Dunn G. Applied multivariate data analysis. London, England: Arnold, 1991; 45-56.
24. Kaiser HF. The varimax criterion for analystic rotation in factor analysis. Psychometrika 1958; 23:187-200.
25. Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Gut 1993; 34:1364-1369.
26. Sans M, Fuster D, Llach J, et al. Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease. Dig Dis Sci 2000; 45: 1828-1835.
27. Molnar T, Papos M, Gyulai C, et al. Clinical value of technetium-99m-HMPAO-labeled leukocyte scintigraphy and spiral computed tomography in active Crohn's disease. Am J Gastroenterol 2001; 96:1517-1521.
28. Biancone L, Scopinaro F, Ierardi M, et al. 99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn's disease. Dig Dis Sci 1997; 42:1549-1556.
29. Weldon MJ, Lowe C, Joseph AE, Maxwell JD. Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy. Aliment Pharmacol Ther 1996; 10: 123-132.
30. Weldon MJ, Masoomi AM, Britten AJ, et al. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT). Gut 1995; 36:243-250.
31. Weldon MJ. Assessment of inflammatory bowel disease activity using 99mTc-HMPAO single-photon emission computerized tomography imaging. Scand J Gastroenterol Suppl 1994; 203:61-68.